AK139
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AK139, covering 2025-04-27 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]